- Home
- HCTI vs SONN Comparison
HCTI vs SONN Comparison
Compare HCTI & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- SONN
- Stock Information
- Founded
- HCTI 2020
- SONN N/A
- Country
- HCTI United States
- SONN United States
- Employees
- HCTI 33
- SONN N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- SONN Health Care
- Exchange
- HCTI Nasdaq
- SONN Nasdaq
- Market Cap
- HCTI 2.2M
- SONN 2.5M
- IPO Year
- HCTI 2021
- SONN N/A
- Fundamental
- Price
- HCTI $0.40
- SONN $1.44
- Analyst Decision
- HCTI
- SONN Strong Buy
- Analyst Count
- HCTI 0
- SONN 2
- Target Price
- HCTI N/A
- SONN $38.00
- AVG Volume (30 Days)
- HCTI 3.9M
- SONN 98.6K
- Earning Date
- HCTI 03-17-2025
- SONN 02-13-2025
- Dividend Yield
- HCTI N/A
- SONN N/A
- EPS Growth
- HCTI N/A
- SONN N/A
- EPS
- HCTI N/A
- SONN N/A
- Revenue
- HCTI $16,565,999.00
- SONN $1,000,000.00
- Revenue This Year
- HCTI $88.31
- SONN N/A
- Revenue Next Year
- HCTI N/A
- SONN N/A
- P/E Ratio
- HCTI N/A
- SONN N/A
- Revenue Growth
- HCTI N/A
- SONN 674.14
- 52 Week Low
- HCTI $0.29
- SONN $1.38
- 52 Week High
- HCTI $2.96
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- HCTI 36.76
- SONN 37.03
- Support Level
- HCTI $0.43
- SONN $1.38
- Resistance Level
- HCTI $0.88
- SONN $1.60
- Average True Range (ATR)
- HCTI 0.10
- SONN 0.09
- MACD
- HCTI -0.02
- SONN -0.01
- Stochastic Oscillator
- HCTI 0.00
- SONN 19.35
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments which are Software Services, Managed Services, and Support and Platform Services.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.